News Headlines Article

Scope makers staying mum at FDA superbug hearing
Los Angeles Business Journal

A Food and Drug Administration panel of medical experts are convening this week to examine the spread of scope-related superbugs at several U.S. hospitals, including those in Los Angeles, but the major scope makers linked to the outbreaks won’t be speaking during the discussions. Olympus Corp. and and two other medical device manufacturers were invited to speak at the hearing but “for various reasons they’ve declined to participate,” the Los Angeles Times quoted Dr. Stephen Ostroff, the FDA’s acting commissioner, as saying.